138 related articles for article (PubMed ID: 23970149)
21. Elevated pre-treatment IL-18 level is associated with HBeAg seroconversion in HIV-HBV coinfection.
Li Y; Xie J; Wang H; Han Y; Wang N; Thio CL; Li T
Antivir Ther; 2017; 22(6):523-527. PubMed ID: 28195558
[TBL] [Abstract][Full Text] [Related]
22. Outcomes in HIV/HBV-Coinfected Patients in the Tenofovir Era Are Greatly Affected by Immune Suppression.
Huang AJ; Núñez M
J Int Assoc Provid AIDS Care; 2015; 14(4):360-8. PubMed ID: 25999329
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
Alvarez-Uria G; Ratcliffe L; Vilar J
HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
[TBL] [Abstract][Full Text] [Related]
24. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
[TBL] [Abstract][Full Text] [Related]
25. Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B.
Dezanet LNC; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A
Liver Int; 2021 Dec; 41(12):2874-2884. PubMed ID: 34297463
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D insufficiency and deficiency among HIV-1-infected patients in a tropical setting.
Wiboonchutikul S; Sungkanuparph S; Kiertiburanakul S; Chailurkit LO; Charoenyingwattana A; Wangsomboonsiri W; Chantratita W; Ongphiphadhanakul B
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(5):305-10. PubMed ID: 22247338
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir.
Casado JL; Bañón S; Santiuste C; Serna J; Guzman P; Tenorio M; Liaño F; del Rey JM
AIDS; 2016 Jan; 30(2):231-9. PubMed ID: 26684820
[TBL] [Abstract][Full Text] [Related]
28. Tenofovir-based antiretroviral therapy in
HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database.
Boettiger DC; Kerr S; Ditangco R; Chaiwarith R; Li PC; Merati TP; Pham TT; Kiertiburanakul S; Kumarasamy N; Vonthanak S; Lee CK; Van Kinh N; Pujari S; Wong WW; Kamarulzaman A; Zhang F; Yunihastuti E; Choi JY; Oka S; Ng OT; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Law M;
Antivir Ther; 2016; 21(1):27-35. PubMed ID: 26069150
[TBL] [Abstract][Full Text] [Related]
29. Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.
Klassen KM; Kimlin MG; Fairley CK; Emery S; Anderson PH; Ebeling PR;
Osteoporos Int; 2016 May; 27(5):1737-45. PubMed ID: 26659069
[TBL] [Abstract][Full Text] [Related]
30. Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
Audsley J; Arrifin N; Yuen LK; Ayres A; Crowe SM; Bartholomeusz A; Locarnini SA; Mijch A; Lewin SR; Sasadeusz J
HIV Med; 2009 Apr; 10(4):229-35. PubMed ID: 19178592
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D Insufficiency/Deficiency in HIV-Infected Inner City Youth.
Poowuttikul P; Thomas R; Hart B; Secord E
J Int Assoc Provid AIDS Care; 2014; 13(5):438-42. PubMed ID: 23881908
[TBL] [Abstract][Full Text] [Related]
32. Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.
Boyd A; Moh R; Gabillard D; le Carrou J; Danel C; Anglaret X; Eholié SP; Maylin S; Delaugerre C; Zoulim F; Girard PM; Lacombe K;
Antivir Ther; 2015; 20(6):643-54. PubMed ID: 25852125
[TBL] [Abstract][Full Text] [Related]
33. Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users.
Childs KE; Fishman SL; Constable C; Gutierrez JA; Wyatt CM; Dieterich DT; Mullen MP; Branch AD
AIDS Res Hum Retroviruses; 2010 Aug; 26(8):855-9. PubMed ID: 20672993
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients.
Guzmán-Fulgencio M; García-Álvarez M; Berenguer J; Jiménez-Sousa MÁ; Cosín J; Pineda-Tenor D; Carrero A; Aldámiz T; Alvarez E; López JC; Resino S
J Infect; 2014 Feb; 68(2):176-84. PubMed ID: 24184809
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
Grant J; Agbaji O; Kramvis A; Yousif M; Auwal M; Penugonda S; Ugoagwu P; Murphy R; Hawkins C
Trop Med Int Health; 2017 Jun; 22(6):744-754. PubMed ID: 28376292
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy.
Coelho L; Cardoso SW; Luz PM; Hoffman RM; Mendonça L; Veloso VG; Currier JS; Grinsztejn B; Lake JE
Nutr J; 2015 Aug; 14():81. PubMed ID: 26283663
[TBL] [Abstract][Full Text] [Related]
37. Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use.
Boyd A; Lasnier E; Molina JM; Lascoux-Combe C; Bonnard P; Miailhes P; Wendum D; Meynard JL; Girard PM; Lacombe K
Antivir Ther; 2010; 15(7):963-74. PubMed ID: 21041911
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection.
El-Maouche D; Mehta SH; Sutcliffe CG; Higgins Y; Torbenson MS; Moore RD; Thomas DL; Sulkowski MS; Brown TT
Antivir Ther; 2013; 18(2):237-42. PubMed ID: 22910231
[TBL] [Abstract][Full Text] [Related]
39. Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents.
Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Sophonphan J; Ananworanich J; Puthanakit T;
Antivir Ther; 2017; 22(6):471-479. PubMed ID: 27786155
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.
Wongprasit P; Manosuthi W; Kiertiburanakul S; Sungkanuparph S
AIDS Patient Care STDS; 2010 Apr; 24(4):205-9. PubMed ID: 20377434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
